DUBLIN--(BUSINESS WIRE)--The "Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering.
The Global Companion Diagnostics Partnering 2010-2018 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Companion Diagnostics agreements announced in the life sciences since 2010.
The report takes the reader through a comprehensive review Companion Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Companion Diagnostics partnering deals.
The report presents financial deal term values for Companion Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
A comprehensive series of appendices is provided organized by Companion Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.
- Trends in Companion Diagnostics dealmaking in the biopharma industry since 2010
- Analysis of Companion Diagnostics deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Companion Diagnostics deals
- Access to Companion Diagnostics contract documents
- Leading Companion Diagnostics deals by value since 2010
- Most active Companion Diagnostics dealmakers since 2010
Available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Companion Diagnostics dealmaking
Chapter 3 - Leading Companion Diagnostics deals
Chapter 4 - Most active Companion Diagnostics dealmakers
Chapter 5 - Companion Diagnostics contracts dealmaking directory
Chapter 6 - Companion Diagnostics dealmaking by technology type
Chapter 7 - Partnering resource center
For more information about this report visit https://www.researchandmarkets.com/research/5nffph/global_companion?w=4